Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This is according to nationally representative survey data of gay and bi men diagnosed with the virus.
With the help of a $6.2 million grant, researchers at Brown University hope to find out.
Whether the donor uses antiretrovirals for HIV treatment or as PrEP, the drugs could mask the presence of the virus in a blood donation.
The HIV advocacy group has been assiduously tracking PrEP data for five years.
The CDC funding goes to 32 state and local health departments as part of a federal initiative.
Products based on broadly neutralizing antibodies could be used in HIV treatment and prevention.
The bill includes support for HIV research, the Ryan White HIV/AIDS programs and more. A date for the full House review has not been set.
A federal grant for a Latino adolescent center in the South Bronx will help evaluate a new peer-based approach.
The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.
The SEARCH study included men and women at elevated risk of HIV in Kenya and Uganda.
The new global pandemic could also lead to greater susceptibility to HIV transmission.
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.
The injectable cabotegravir, given every eight weeks, is just as effective as daily Truvada for HIV prevention.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.